Cleveland Biolabs (CBLI) Reports Q2 Loss of $1.12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Cleveland BioLabs Reports Second Quarter 2015 Financial Results and Development Progress
August 12, 2015 7:30 AM EDTBUFFALO, NY -- (Marketwired) -- 08/12/15 -- Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported financial results and development progress for the second quarter and for the six-month period ended June 30, 2015.
Cleveland BioLabs reported a $4.4 million net loss for the second quarter of 2015, or $1.12 per share, compared to a net loss of $4.0 million, or $1.53 per share, for the same period in 2014. Net loss for the first six months of 2015 was $8.1 million, or $2.25 per share, compared to a net loss of $5.5 million, or $2.18 per share, for the same period in 2014. The... More
